THThe Hindu·7hHealth
score+0.75
CDSCO clears recombinant live attenuated dengue vaccine for ages 4 to 60 years
Original
CDSCO clears recombinant live attenuated dengue vaccine for ages 4 to 60 years
“Regulatory approval framed as achievement with emphasis on safety and efficacy evaluation, using constructive language.”